UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Interplay between the SAFE and the sphingolipid pathway for cardioprotection

Cour, M; Pedretti, S; Nduhirabandi, F; Hacking, D; Frias, MA; Hausenloy, DJ; Lecour, S; (2024) Interplay between the SAFE and the sphingolipid pathway for cardioprotection. Life Sciences , 358 , Article 123145. 10.1016/j.lfs.2024.123145.

[thumbnail of LFS-D-24-05896_R2.pdf] Text
LFS-D-24-05896_R2.pdf - Accepted Version
Access restricted to UCL open access staff until 18 October 2025.

Download (4MB)

Abstract

Aim: Activation of both the Survivor Activating Factor Enhancement (SAFE) pathway (including Tumor Necrosis Factor-alpha (TNF-α) and Signal Transducer and Activator of Transcription-3 (STAT-3)) and the sphingolipid signalling pathway (including sphingosine kinase-1 (SK1) and sphingosine-1 phosphate (S1P)) play a key role in promoting cardioprotection against ischemia-reperfusion injury (IRI). We investigated whether the activation of the SAFE pathway by exogenous S1P is dependent on the activation of SK1 for cardioprotection. Materials and methods: Isolated cardiomyocytes from TNF-α knockout (KO) mice, cardiomyocyte-specific STAT-3 KO mice and their wild-type (WT) littermates were exposed to simulated ischemia in the presence of a trigger of the SAFE pathway (S1P) and SK1 inhibitor (SK1-I). Similarly, isolated perfused hearts from adult TNF-α KO, STAT-3 KO and WT mice were subjected to IRI with S1P and/or SK1-I. Cell viability, infarct size (IS) and SK1 activity were assessed. Key findings: In isolated cardiomyocytes and in isolated hearts subjected to simulated ischemia/IRI, S1P pretreatment decreased cell death in WT mice, an effect that was abrogated in the presence of SK1-I. S1P failed to reduce cell death after simulated ischemia/IRI in both cardiomyocytes or hearts isolated from TNF-α KO and STAT-3 KO mice. Interestingly, S1P pretreatment increased SK1 activity in WT and STAT-3 KO mice, with no changes in TNF-α KO mice. Significance: Our data strongly suggest SK1 as a key component to activate STAT-3 downstream of TNF-α in the SAFE pathway, paving the way for the development of novel cardioprotective strategies that may target SK1 to modulate the SAFE pathway and increase cell survival following IRI.

Type: Article
Title: Interplay between the SAFE and the sphingolipid pathway for cardioprotection
Location: Netherlands
DOI: 10.1016/j.lfs.2024.123145
Publisher version: http://dx.doi.org/10.1016/j.lfs.2024.123145
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Ischemia-reperfusion injury, Mitochondria, Signal transducer and activator of transcription 3, Sphingolipid, Survivor activating factor enhancement pathway, Tumor necrosis factor alpha
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10200280
Downloads since deposit
11Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item